NYSE · ATR
Healthcare · Medical - Instruments & Supplies
$124.68
Down-$0.23 (-0.18%)
Updated Sep 16, 2026, 7:48 AM
SID Score
4.8/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
ATR closed at $124.68 after 20 trading sessions, down 5.35% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $124.85 | $124.86 | $123.405 | $124.68 | 474.73K |
| Sep 14, 2026 | $125.28 | $126.21 | $124.00 | $124.91 | 423.16K |
| Sep 11, 2026 | $124.85 | $125.595 | $123.06 | $124.84 | 491.93K |
| Sep 10, 2026 | $122.05 | $123.12 | $120.74 | $123.05 | 435.09K |
| Sep 9, 2026 | $123.97 | $123.97 | $121.09 | $122.11 | 383.03K |
| Sep 8, 2026 | $126.20 | $126.99 | $124.25 | $124.34 | 362.19K |
| Sep 4, 2026 | $127.53 | $128.4699 | $126.525 | $127.41 | 323.99K |
| Sep 3, 2026 | $130.65 | $130.65 | $126.99 | $128.31 | 339.99K |
| Sep 2, 2026 | $131.27 | $132.26 | $129.69 | $130.33 | 472.48K |
| Sep 1, 2026 | $131.65 | $132.07 | $130.7825 | $130.92 | 418.16K |
| Aug 31, 2026 | $132.21 | $132.44 | $130.83 | $131.62 | 389.24K |
| Aug 28, 2026 | $133.55 | $133.655 | $132.04 | $132.99 | 325.43K |
| Aug 27, 2026 | $133.78 | $134.69 | $132.26 | $132.86 | 295.69K |
| Aug 26, 2026 | $135.00 | $136.64 | $134.435 | $135.24 | 281.38K |
| Aug 25, 2026 | $135.59 | $135.59 | $133.22 | $134.72 | 280.92K |
| Aug 24, 2026 | $135.36 | $136.34 | $134.39 | $134.75 | 282.3K |
| Aug 21, 2026 | $134.04 | $135.125 | $133.10 | $134.80 | 400.5K |
| Aug 20, 2026 | $131.45 | $133.83 | $130.90 | $132.96 | 420.89K |
| Aug 19, 2026 | $133.05 | $134.3799 | $132.285 | $132.93 | 390.42K |
| Aug 18, 2026 | $132.75 | $133.465 | $131.22 | $131.73 | 500.15K |
The latest Smart Investors Daily articles mentioning ATR.
ATR research
Company profile and research snapshot.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 3, 2026 | Wells Fargo | Overweight | — |
| May 4, 2026 | Wells Fargo | Overweight | — |
| Mar 20, 2026 | Wells Fargo | Overweight | — |
| Jan 6, 2026 | Wells Fargo | Equal-Weight | — |
| Nov 3, 2025 | Wells Fargo | Overweight | — |
No generated briefing is available yet.
SeekingAlpha · Sep 9, 2026
AptarGroup, Inc. (ATR) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 12:45 PM EDTCompany ParticipantsGael Touya - CEO, President &...
Yahoo · Aug 14, 2026
West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.
Yahoo · Aug 13, 2026
WST's HVP growth, wider margins and raised 2026 outlook support its recent rally, but a premium valuation raises the bar for further gains.
Yahoo · Aug 3, 2026
Review AptarGroup's (ATR) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ATR.
